title: The role of hepatobiliary scintigraphy in the follow-up of benign liver tumors secondary to oral contraceptive use.
authors.affiliation: Department of Nuclear Medicine, Haemek Medical Center, Afula, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Bykov
authors.forename: I
authors.initials: I
authors.lastname: Garty
authors.forename: L
authors.initials: L
authors.lastname: Cherevinsky
authors.forename: O
authors.initials: O
authors.lastname: Segol
authors.forename: D
authors.initials: D
authors.lastname: Lumelsky
mesh_terms: D000328:Adult; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D005710:Gallium Radioisotopes; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D015609:Organotechnetium Compounds; D010833:Phytic Acid; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D014463:Ultrasonography
chemical_list: D003278:Contraceptives, Oral, Hormonal; D005710:Gallium Radioisotopes; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C026177:technetium phytate; D010833:Phytic Acid